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Abstract
Altitude hypoxia is often associated with impairment of human reproduction.
In this study, hormones and macrophage migration inhibitory factor (MIF, a
proinflammatory cytokine with key roles in human reproduction) were deter-
mined in seven regularly menstruating, lowlander native women living at sea
level participating in 14 days of trekking at moderate and high altitude. Blood
and saliva samples were collected from each subject at high altitude (5050 m
a.s.l. [above sea level]), and at sea level before and after the expedition.
Testosterone level was lowered by high altitude and was restored after the end
of the expedition, while progesterone decreased significantly in all participants
at the end of the expedition, although most of the participants were in the
luteal phase. The salivary concentration of MIF decreased greatly at altitude,
but its levels were completely restored after the return to sea level. Our find-
ings showed high sensitivity and rapid changes in the determined parameters
in response to the high-altitude hypoxic environment, particularly MIF.
Introduction
Blood oxygen levels are crucial for survival as oxygen
serves basic cell functions and complex mechanisms in
all physiological systems. However, some environmental
conditions, for example, high altitude, can significantly
affect oxygen availability, with consequent short- and/or
long-term body adjustments. About that, it is well
known that chronic exposure to altitude causes reversi-
ble fertility impairments, in humans who are not well
adapted (Donayre et al. 1968; Okumura et al. 2003; Ver-
ratti et al. 2007, 2016a; Pelliccione et al. 2011), but it
does not cause adverse effects on fertility in populations
that settle permanently in regions of high altitude (Far-
ias et al. 2005).
Regarding the female reproductive system, studies on
high-altitude residents have shown that pregnancy and
neonatal conditions can be adversely affected by “high alti-
tude.” Intrauterine growth restriction reduces birth weight
in high-altitude infants (Jensen and Moore 1997). Pre-
eclampsia is more common in mothers living at high alti-
tude than low altitude (Harrison and Moore 1990; Zamu-
dio et al. 1993, 1995). Moreover, studies on the influence
of the menstrual cycle phase on acclimatization to high
altitude have dealt with sympathetic nerve activity and
other various metabolic activities (Mazzeo et al. 1998;
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Brutsaert et al. 2002). Compared to the lowlander native
women living at sea level, high-altitude native women liv-
ing at high altitude have a shorter reproductive life span
because of delayed menarche and earlier menopause (Gon-
zales and Villena 1996), a longer duration of the follicular
phase and an earlier occurrence of ovulation after the peak
of luteinizing hormone (LH) (Escudero et al. 1996). On
the other hand, an extensive study of indigenous Andean
population showed no significant changes in the menstrual
cycle (length or regularity) compared to lowlander native
women living at sea level (Vitzthum 2001). The high-alti-
tude indigenous habitants (Himalayan and Andean) seem
to have adapted to the hypoxic environment without clear
and notable negative impacts on fertility (Vitzthum and
Wiley 2003; Vitzthum 2013).
Gonadal hormones are the key factors in reproductive
capacity, but also in the neural control of respiration.
Testosterone, estradiol, and progesterone were found to
be affected by hypoxia, while sex hormones are known to
cross the blood–brain barrier, and their receptors have
been found in central and peripheral structures that regu-
late respiration (Behan and Kinkead 2001). Progesterone
levels detected during the luteal phase of high-altitude
native women inhabitants living at high altitude were
found to be lower than those in comparable samples of
lowlander native women living at sea level (Escudero
et al. 1996; Jiang et al. 2000; Vitzthum 2001).
Another important molecule related to reproduction is
macrophage migration inhibitory factor (MIF), occurring
in the cycling uterus in preparation for pregnancy (Pau-
lesu et al. 2010). MIF is also produced at the implanta-
tion site by the human placenta, and MIF production is
regulated by the low oxygen tension, characterizing the
uterine environment in early gestation (Ietta et al. 2007).
The importance of MIF during the establishment of preg-
nancy was revealed by Yamada et al. (2003), who showed
that women suffering recurrent early miscarriages had
lower maternal MIF plasma levels.
The aim of this study was to examine the hormone
and MIF responses in seven healthy, regularly menstruat-
ing, native women living at sea level who participated in
the Gokyo Khumbu/Ama Dablam Trek 2012-Scientific
Expedition, involving 14 days of trekking at moderate
and high altitude.
Materials and Methods
The Gokyo Khumbu/Ama Dablam Trek 2012 was a
broad research project involving different areas of physi-
ology, as evidenced by recent publications (Pietrangelo
et al. 2015; Mancinelli et al. 2016; Morabito et al. 2016;
Scordella et al. 2016; Tam et al. 2016; Verratti et al.
2016b).
Subjects
This study was carried out on seven fertile females
(36.3  7.1 years old) resident at sea level who reported a
very regular menstrual cycle (28  1 days per cycle). The
voluntary participants were all healthy, with no history of
pregnancy or chronic diseases. They were all moderately
trained trekkers; none of them took steroid hormones
before or during the trek. Each subject signed a “declara-
tion of risk acceptance and assumption of responsibility,”
and authorized personal data collection and processing.
The study was approved by the Bioethics Committee of
“G. d’Annunzio” University of Chieti-Pescara (Italy, proto-
col no. 773 COET), and was designed in accordance with
the recommendations of the Declaration of Helsinki.
Experimental protocol
Blood (for hormone determinations) and saliva (for MIF
determination) samples were collected three times: (1) at
sea level before (day 14 [before]), (2) during the high-
altitude trekking phase (day 14 [high altitude]) and (3) at
sea level, after high-altitude trekking (Day+1 [after]), while
the peripheral oxygen saturation (SpO2) measurements
were made 14 times (including the three measurements
carried out at day 14 [before], at day 14 [at high altitude],
and at day+1 [after]), to better trace the saturation profile
during shipment. The details of the three phases of the
experimental protocol are given in Table 1. The altimetry
map for the expedition is shown in Figure 1 (Upper). At
each of the three data collection points, the volunteers were
interviewed, menstrual cycle data were recorded, and blood
and saliva samples were collected. The volunteers were
interviewed about health conditions during the altitude
trek.
Measurements
Saturation of peripheral oxygen
SpO2 was recorded for about 2 min by pulse oximetry
from the fingertip (503 OXY-5 GIMA; Gima S.p.A., Ges-
sate, Italy). SpO2 parameter specifications: measuring
range (35–99%); accuracy (2% during 75–99%, 3%
during 50–74%).
Hormones
Women of reproductive age undergo hormonal changes
during the menstrual cycle. However, we chose not to
artificially alter the hormonal cycles and not to synchro-
nize the cycle in the subjects, in order to examine the
potential impact of altitude on menstrual cycle
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physiology. Therefore, the subjects were in different men-
strual phases at the time of the sampling.
Blood samples (5 mL) were collected by venipuncture
in the morning, and centrifuged (3000g for 10 min), after
which serum samples were frozen in liquid nitrogen. On
the day of testing, they were thawed and assayed for the
following hormones: thyroid-stimulating hormone
(TSH), LH, follicle-stimulating hormone (FSH), prolactin,
testosterone, estradiol, progesterone, free triiodothyronine
(FT3), free thyroxine (FT4), and cortisol (ADVIA Centaur
CP Immunoassay System; Siemens Healthcare, Milan, Italy).
Salivary MIF
A saliva sample was taken in the morning, right after
the blood sample, by Salivette Cotton Swab (Starstedt,
N€umbrecht, Germany). Participants were asked to gently
chew the swab for approximately 2 min. Following each
collection, the swab was frozen at 20°C until taken to
the laboratory at University of Siena (Italy). On the day
of sample analysis, the samples were centrifuged after
thawing and assayed for the cytokine MIF using a col-
orimetric sandwich enzyme-linked immunosorbent assay
protocol developed by Ietta et al. (2002) at the Univer-
sity of Siena, Italy. Intra- and interassay coefficients of
variation were 3.86 (0.95) and 9.14 (0.47), respectively.
The MIF concentration was expressed as ng/mL of
saliva.
Statistical analysis
All collected data were analyzed by Friedman ANOVA
for the three data collection points (Day 14 [before],
Day 14 [high altitude], and Day +1 [after]), followed
Table 1. Details of the experimental protocol.
1 Meeting at University of Chieti-Pescara (110 m a.s.l., “Sea level before”) 14 days before the beginning of the expedition (day 14)
2 The Gokyo Khumbu/Ama Dablam Trek 2012-Scientific Expedition started in Rome on 23 October 2012 (day 1) and ended in the same
city on 12 November 2012 (day 21). After the flight from Rome to Kathmandu (Nepal), the expedition group remained in Kathmandu the
following day to define organizational, managerial, and strategic activities for the high-altitude trek. At day 4, the group flew
from Kathmandu to Lukla (2800 m a.s.l.) where the altitude trek started. After 2 days of moderate-altitude trekking the group
reached Namche Bazaar (3440 m a.s.l.) where it spent 1 day at rest. The group then reached the Ev-K2 Italian CNR Desio’s
Pyramid (5050 m a.s.l.) and rested there for 1 day (High altitude, day 14). The end of the trek at Lukla, on day 17, coincided
with the end of the hypoxic experience for the expedition members. The group then flew to Kathmandu and then back to Rome
(day 21). In total, the scientific expedition lasted 21 days with 14 days of trekking at moderate and high altitude including 2 days
spent at rest at altitude.
3 Meeting at University of Chieti-Pescara (110 m a.s.l., “Sea level after”) 1 day after the end of the expedition (day +1).
a.s.l., above sea level.
Figure 1. Upper: altimetry during the scientific expedition from Rome (day 1) to Rome (day 21) and at the data collection in Chieti before (day
14) and after (day +1) the expedition. Two days were spent at altitude, the first at Namche Bazaar (3400 m a.s.l.) and the second at Desio’s
Pyramid (5050 m a.s.l.). Lower: SpO2 (%) values recorded at different altitudes during the expedition and at sea level before (day 14) and
after (day +1) the expedition. a.s.l., above sea level; SpO2, saturation of peripheral oxygen.
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by Wilcoxon matched pairs test when appropriate to
evaluate the effect of altitude on the different parame-
ters (details are reported in the Results section). In the
figures and tables, the data are expressed as
mean  SEM.
Results
The expedition was successful with no serious organiza-
tional problems; weather conditions were good, with dry
sunny days and with an average temperature of about
11°C at Lukla (2800 m a.s.l.), 7°C in Namche Bazar
(3440 m a.s.l.), and 1°C at Gorak Shep (5186 m a.s.l.),
as recorded throughout October and November. No sig-
nificant health problems and no alterations of menstrual
cycle length were recorded during the altitude trek in any
of the subjects. Table 2 shows the changes in weight for
each subject by altitude.
Saturation of peripheral oxygen
As expected, SpO2 was significantly affected by altitude
(Friedman ANOVA [N = 7, df=2] = 11.76, P < 0.002).
There was a progressive decrease in oxygenation until day
12, followed by a return to normal values at the end of
the expedition (Fig. 1, Lower).
Hormones
Estradiol
There were no significant differences in estradiol levels
among the three determinations (Friedman ANOVA [N = 7,
df=2] = 2, P = 0.36), although, as seen in Figure 2A, the val-
ues tended to decrease at high altitude compared to sea level
(recorded before and after the expedition).
Progesterone
Progesterone levels (Fig. 2B) showed significant changes
among the data collection points (Friedman ANOVA [N = 7,
df=2] = 9.5 P < 0.008) with lower values at sea level after the
expedition than during the first two points (P < 0.04).
FSH and LH
FSH and LH levels (Fig. 2C and D, respectively) did not
show significant differences among the three data collec-
tions (Friedman ANOVA [N = 7, df=2] = 3.71, P = 0.15
and [N = 7, df=2] = 2.00, P = 0.37, respectively).
Testosterone
Testosterone levels (Fig. 2E) differed significantly among
the three data collection points (Friedman ANOVA
[N = 7, df=2] = 12.07, P < 0.002), with lower levels
recorded at altitude than at sea level before and after the
expedition (P < 0.01 both).
Prolactin
Prolactin levels (Fig. 2F) differed significantly among the
three data collection points (Friedman ANOVA [N = 7,
df=2] = 6.00, P = 0.04), with lower values at sea level
after the expedition than at altitude (P < 0.02).
Cortisol
Cortisol levels (Fig. 2G) did not show significant changes
among the three data collection points (Friedman
ANOVA [N = 7, df=2] = 0.28, P = 0.86).
TSH
TSH levels (Fig. 2H) differed significantly among the
three data collection points (Friedman ANOVA [N = 7,
df=2] = 9.55, P < 0.008), with lower levels at the third
data collection point than at the other two (P < 0.01 and
0.02, respectively).
FT3 and FT4
FT3 levels did not show significant changes in any of the
three data collection points (Friedman ANOVA [N = 7,
df=2] = 3.71, P = 0.15, Fig. 2J), while FT4 (Fig. 2I) did
differ significantly (Friedman ANOVA [N = 7, df=2] =
P < 0.04), with higher levels at the third point than at
the first and second (P < 0.03 and P < 0.02, respec-
tively).
Table 2. Body weight of participants in the high-altitude
expedition.
Subject ID Age
Body weight (kg)
Sea level
before
High
altitude
Sea level
after
1 41 68.6 70.5 67
2 32 56.5 56.4 55.8
3 28 60.4 58.4 58.8
4 48 60.7 64.1 62
5 31 59 60 60
6 36 49.8 49.1 49
7 37 85 84.3 84.5
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Figure 2. (A–J) Serum hormone levels at the three data collection points (sea level before-high altitude-sea level after). *P < 0.05 versus sea
level before, #P < 0.05 versus high altitude. (A) average estradiol (E2) value (pg/mL); (B) average progesterone (P) value (ng/mL); (C) average
follicle-stimulating hormone (FSH) value (mUL/mL); (D) average luteinizing hormone (LH) value (mUL/mL); (E) average testosterone (T) value (ng/
mL); (F) average prolactin (Pro) value (pg/mL); (G) average cortisol (C) value (pg/mL); (H) average thyroid-stimulating hormone (TSH) value (ng/
mL); (I) average free thyroxine (FT4) value (pg/mL) and (J) average free triiodothyronine (FT3) value (pg/mL) among the three determinations.
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Migration inhibitory factor
As shown in Figure 3, Friedman ANOVA applied to sali-
vary MIF revealed significant differences among the three
data collection points ([N = 6, df 2] = 9.00, P < 0.01),
highly decreased lower levels observed in samples col-
lected at high altitude compared to sea level (P < 0.02,
both points).
Discussion
The young women participating in the Gokyo Khumbu/
Ama Dablam Trek 2012-Scientific Expedition (14 days of
trekking at moderate and high altitude) were subjected to
high-altitude hypoxia, resulting in a significant decrease
in plasma testosterone and salivary MIF, while, from sta-
tistical point of view, progesterone significantly decreased,
after high-altitude exposure, similarly to prolactin.
The results of this study, particularly those on proges-
terone, clearly suggest the possibility of long-lasting
changes in the hypothalamus–pituitary–gonadal axes, sup-
porting the importance of hormonal studies, not only
before and during but also after the return to the sea
level. Indeed, in accordance with previous studies on
native women living at sea level and temporarily exposed
to altitude (Reeves et al. 2001), the progesterone levels
determined at high altitude showed no significant differ-
ence from those obtained in the subjects in the same
menstrual phase at sea level before the expedition. How-
ever, an important inhibitory effect on progesterone
secretion became evident at the data collection carried
out after the return to sea level when all women were in
the luteal phase (18–28 days) of the menstrual cycle: the
progesterone levels were expected to be over 5 ng/mL,
whereas the recorded levels were close to zero, a value
below any acceptable concentration limit. These results
clearly show that no ovulation occurred in any woman
during the expedition. Moreover, the increased FSH and
LH levels after the end of the expedition (although not
statistically significant) support an insufficient suppressive
effect on the pituitary gland by progesterone.
The testosterone levels were also reduced by altitude,
but this effect was limited to the high-altitude exposure;
hence, this reduction can be attributed to a direct effect
of hypoxia. On the other hand, we demonstrated previ-
ously that testosterone plasma levels can be increased by
O2 supplementation in young adult men in hyperbaric
conditions (Passavanti et al. 2010).
Estradiol tended to decrease by altitude, as a possible
direct consequence of the lack of testosterone as a sub-
strate for aromatase activity (androgen to estrogen).
Interestingly, Perez-Sepulveda et al. (2015) reported
lower aromatase expression in the placenta from preg-
nancies complicated by pre-eclampsia (Zamudio et al.
1995). A lower 17-b estradiol/testosterone ratio was also
found in the maternal circulation of pregnant women
suffering from pre-eclampsia (Perez-Sepulveda et al.
2015).
The ability of hypoxia to modulate the hypothalamic–
pituitary–gland axis was carried out mostly in men. In
these studies, TSH, the pituitary factor, and the thyroid
hormones T3 and T4 were found to be differently affected
in the different experimental conditions (Richalet et al.
2010). Thyroid hormones can play an important role in
adaptation because, among the other effects, they change
the functioning of erythrocytes, facilitating oxygen release
to the tissues (Snyder and Reddy 1970). The slight
increase in TSH, observed in this study at altitude (not
significant) can be explained by the adaptation to the
need to increase oxygen availability, the decrement
observed at sea level after the trek can be explained by a
feedback effect; indeed, the FT4 at that determination
showed the highest value. Interestingly, prolactin changes
were also similar to those observed for TSH with the low-
est levels after the return to sea level. This result was
expected, considering the common modulation of TRH
not only on the TSH but also on prolactin production.
Another important aspect of this study was the inflam-
matory response to altitude shown by the MIF concentra-
tions. We selected this cytokine based on previous studies
of human reproduction and the proinflammatory role of
MIF in different pathophysiological processes (Aloisi et al.
2005; Nishihira and Mitsuyama 2009; Paulesu et al.
2010).
In an important study of Aloisi and collaborators, on
chronic pain patients, we found that in these subjects,
MIF levels were very low and that its concentration was
positively correlated with testosterone (Aloisi et al. 2005).
Figure 3. Salivary MIF concentrations at the three data collection
points. *P < 0.05 versus sea level before; #P < 0.05 versus high
altitude. MIF, migration inhibitory factor.
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In this study, we can hypothesize that similarly to
patients, low testosterone condition (present in all women
at high altitude) can reduce MIF availability. The low
testosterone levels found in the trekkers in this study sug-
gest a close relationship between these factors, which goes
beyond their original roles in the control of reproduction.
In spite of the extremely low levels in salivary MIF at high
altitude, other studies showed that placental tissues from
high-altitude women inhabitants had higher MIF concen-
trations than those from lowland native women living at
sea level (Ietta et al. 2007). We can hypothesize that in
high-altitude pregnant women, a compensative MIF
response may occur locally, in the placenta to assure the
maintenance of pregnancy. However, while this adapta-
tion seems beneficial to fetal survival, it may become
detrimental by contributing to the development of mater-
nal pre-eclampsia, a severe complication in pregnancy,
more common in mothers living at high altitude than at
low altitude (Zamudio et al. 1995; Cardaropoli et al.
2012).
Several other studies have shown adaptive biological
mechanisms in high-altitude pregnancies. Beall et al.
(2004) observed that Tibetan women with genotypes for
high oxygen saturation of hemoglobin had higher offspring
survival than women with low oxygen saturation geno-
types. In a more recent review paper, Illsley et al. (2010)
clearly described how the insufficient oxygen in high-alti-
tude pregnancy leads to a decrease in fetal growth in favor
of cell survival. The authors demonstrated that metabolic
reprogramming in the placenta decreases mitochondrial
oxygen consumption and increases anaerobic glucose con-
sumption. Hence, oxygen supply is increased to assure fetal
survival but at the cost of less glucose availability.
In this study, the cortisol levels were not significantly
affected by altitude, unlike those of testosterone. How-
ever, as MIF is also part of the hypothalamus–pituitary–
adrenal axis, it contributes to the response to stress (e.g.,
evidence shows that MIF is secreted by the same pituitary
cells that secrete adrenocorticotropic hormone (ACTH),
Bernhagen et al. 1993; Nishino et al. 1995; Petrovsky and
Bucala 2000). The findings might also reflect an inte-
grated systemic response to the various stimuli to which
the subjects were exposed, including altitude, type of
food, physical exhaustion, and others.
Limitations of the study
This study has some limitations: (1) it involved a small
number of participants (Donayre et al. 1968); (2) each
participant was in her normal cycle. At the data collec-
tion points at sea level before the altitude expedition,
three participants were in the follicular phase, two in
the postovulatory and two in the luteal phase; (3) no
controls were available for diet, climate, or time
changes. All these limitations make the data prelimi-
nary, and any interpretation must be speculative. How-
ever, some points need to be emphasized in favor of
the validity of the data: (1) our choice not to synchro-
nize the cycle or to give oral contraceptives to the par-
ticipants is advantageous for the study of menstrual
cycle physiology; (2) all subjects were moderately but
sufficiently trained to support the climb program, wisely
planned in accordance with the load of exercise carried
out and a correct altimetric adaptation.
Conclusion
This study highlights the changes that lowlander native
women living at sea level (temporarily exposed to high-
altitude zones) might undergo, probably due to the
change in oxygen saturation during the ascent to high
altitude, and suggests possible factors involved in repro-
ductive impairment.
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